World's Best Scientists 2026 revealed!
A. Michael Lincoff

A. Michael Lincoff

D-Index & Metrics

Medicine

D-Index
125
Citations
63859
World Ranking
3072
National Ranking
1696

A. Michael Lincoff publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where A. Michael Lincoff sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 514 publications — 60th percentile

60% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

A. Michael Lincoff D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where A. Michael Lincoff sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 125 D-Index — 85th percentile

85% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

A. Michael Lincoff is affiliated with the Cleveland Clinic in the United States. Their research activities encompass a broad range of topics within medicine, particularly focusing on cardiology and cardiovascular medicine, endocrinology, diabetes, metabolism, surgery, molecular biology, and pharmacology.

Their scholarly work concentrates on several main topics including:

  • Lipoproteins and Cardiovascular Health
  • Diabetes Treatment and Management
  • Acute Myocardial Infarction Research
  • Metabolism, Diabetes, and Cancer
  • Pharmacology and Obesity Treatment
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Cancer, Lipids, and Metabolism

Lincoff has published extensively in high-profile journals. The frequent publication venues for their work include:

  • Circulation
  • Journal of the American College of Cardiology
  • American Heart Journal
  • New England Journal of Medicine
  • Circulation Cardiovascular Quality and Outcomes

Among the recent papers authored or co-authored by Lincoff are:

  • Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes, 2023, New England Journal of Medicine
  • Cardiovascular Safety of Testosterone-Replacement Therapy, 2023, New England Journal of Medicine

Lincoff has collaborated frequently with several co-authors, including:

  • Stephen J. Nicholls
  • Steven E. Nissen
  • Venu Menon
  • Samir Kapadia
  • Umesh N. Khot

The scope of Lincoff's research reflects a multidisciplinary approach integrating clinical cardiology, metabolic disorders, and pharmacological treatments, often targeting cardiovascular risk factors and therapeutic outcomes. Their work contributes to ongoing understanding in obesity management, cardiovascular safety of hormone therapy, and cardiovascular events associated with lipid therapies.

Best Publications

  • ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction)...

    Jeffrey L. Anderson;Cynthia D. Adams;Elliott M. Antman;Charles R. Bridges

  • Prevalence of Conventional Risk Factors in Patients With Coronary Heart Disease

    Umesh N. Khot;Monica B. Khot;Christopher T. Bajzer;Shelly K. Sapp

  • Bivalirudin for Patients with Acute Coronary Syndromes

    Gregg W. Stone;Brent T. McLaurin;David A. Cox;Michel E. Bertrand

  • Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials.

    A. Michael Lincoff;Kathy Wolski;Stephen J. Nicholls;Steven E. Nissen

  • Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators.

    Eric Boersma;Karen S. Pieper;Ewout W. Steyerberg;Robert G. Wilcox

  • Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade Compared With Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary Intervention: REPLACE-2 Randomized Trial

    A. Michael Lincoff;John A. Bittl;Robert A. Harrington;Frederick Feit

  • Marked Inflammatory Sequelae to Implantation of Biodegradable and Nonbiodegradable Polymers in Porcine Coronary Arteries

    Willem J. van der Giessen;A. Michael Lincoff;Robert S. Schwartz;Heleen M.M. van Beusekom

  • 2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

    Jeffrey L. Anderson;Cynthia D. Adams;Elliott M. Antman;Charles R. Bridges

  • Treatment and Prevention of Heparin-Induced Thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)

    Theodore E. Warkentin;Andreas Greinacher;Andreas Koster;A. Michael Lincoff

  • Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY trial

    Steven V. Manoukian;Frederick Feit;Roxana Mehran;Michele D. Voeltz

  • Comparison of Pioglitazone vs Glimepiride on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes: The PERISCOPE Randomized Controlled Trial

    Steven E. Nissen;Stephen J. Nicholls;Kathy Wolski;Richard Nesto

  • Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial.

    EJ Topol;AM Lincoff;RM Califf;EM Ohman

  • Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes

    Pierluigi Tricoci;Zhen Huang;Claes Held;David J. Moliterno

  • Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis

    Steven E Nissen

  • Intravenous Platelet Blockade with Cangrelor during PCI

    Deepak L. Bhatt;A. Michael Lincoff;C. Michael Gibson;Gregg W. Stone

  • Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease

    A. Michael Lincoff;Stephen J. Nicholls;Jeffrey S. Riesmeyer;Philip J. Barter

  • Platelet Inhibition with Cangrelor in Patients Undergoing PCI

    Robert A. Harrington;Gregg W. Stone;Steven McNulty;Harvey D. White

  • 2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American Academy of Family Physicians, Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons.

    Wright Rs;Anderson Jl;Adams Cd;Bridges Cr

  • Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial.

    Stephen J. Nicholls;A. Michael Lincoff;Michelle Garcia;Dianna Bash

  • Pioglitazone and Risk of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus

    A. Michael Lincoff;Kathy Wolski;Stephen J. Nicholls;Steven E. Nissen

Frequent Co-Authors

Eric J. Topol
Eric J. Topol Scripps Research Institute
Robert M. Califf
Robert M. Califf Duke University
Robert A. Harrington
Robert A. Harrington Cornell University
Stephen G. Ellis
Stephen G. Ellis Cleveland Clinic
Roxana Mehran
Roxana Mehran Icahn School of Medicine at Mount Sinai
Neal S. Kleiman
Neal S. Kleiman Houston Methodist
Deepak L. Bhatt
Deepak L. Bhatt Mount Sinai Hospital
James E. Tcheng
James E. Tcheng Duke University
Steven E. Nissen
Steven E. Nissen Cleveland Clinic
E. Magnus Ohman
E. Magnus Ohman Duke University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a career in Medicine in the USA can open a variety of alternative and supportive pathways, especially through online education. Many students pursue advanced nursing roles, which offer flexibility and promising career prospects.

For those seeking leadership or academic positions, doctorate in nursing education online programs provide the opportunity to deepen expertise without putting a career on hold. If you're a registered nurse, cheapest rn to bsn online programs can help you earn a bachelor’s degree affordably and quickly—a key step for career advancement.

Individuals with non-nursing backgrounds can also make a transition into healthcare through direct msn programs online, which allow entry to a master's in nursing without prior nursing credentials. Additionally, for those concerned about admissions competitiveness, exploring the easiest bsn program to get into can help you find accessible options to launch your healthcare journey.

These online pathways make it possible to advance or pivot to a medical-focused career while balancing personal and professional commitments.

Best Scientists Citing A. Michael Lincoff

Trending Scientists

Recently Published Articles